Douglas R. Dirschl to Cost-Benefit Analysis
This is a "connection" page, showing publications Douglas R. Dirschl has written about Cost-Benefit Analysis.
Connection Strength
0.320
-
Hyaluronic Acid Injections for Treatment of Advanced Osteoarthritis of the Knee: Utilization and Cost in a National Population Sample. J Bone Joint Surg Am. 2016 Sep 07; 98(17):1429-35.
Score: 0.119
-
AOA Symposium. Gainsharing in orthopaedics: passing fancy or wave of the future? J Bone Joint Surg Am. 2007 Sep; 89(9):2075-83.
Score: 0.064
-
Post-fracture care programs for prevention of subsequent fragility fractures: a literature assessment of current trends. Osteoporos Int. 2022 Aug; 33(8):1659-1676.
Score: 0.044
-
Reuse of external skeletal fixator components: effects on costs and complications. J Trauma. 1998 May; 44(5):855-8.
Score: 0.033
-
Cost-effectiveness Analysis of Hip Arthroscopic Surgery and Structured Rehabilitation Alone in Individuals With Hip Labral Tears: Response. Am J Sports Med. 2017 03; 45(3):NP2-NP4.
Score: 0.031
-
The Economic Impact of Acetabular Labral Tears: A Cost-effectiveness Analysis Comparing Hip Arthroscopic Surgery and Structured Rehabilitation Alone in Patients Without Osteoarthritis. Am J Sports Med. 2016 07; 44(7):1771-80.
Score: 0.029